Morris et al. reported that SPINT2 promoter methylation was observed in approximately 30% of ccRCC and 40% of pRCC patients with sporadic type, and they concluded that epigenetic inactivation caused loss of tumor suppressor activities in RCC [45]. The gene discussed is SPINT2; the disease is renal cell carcinoma.